GH Since 2018 Annualized Return and Average Annual Return

GH Average Annual Return Chart Since 2018
Growth of $10,000.00
Without Dividends Reinvested Into GH

Also see:
• GH stock yearly return 2019
• GH stock yearly return 2020
• GH stock yearly return 2021
• GH stock yearly return 2022
• GH stock yearly return 2023
• GH stock yearly return 2024
• GH stock yearly return 2025
• GH YTD return
Average Annual Return Benchmarks
Compare GH average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
GH Share Performance
GH Average Annual Return Table Since 2018
Start date: 10/05/2018
End date: 06/10/2026
Start price/share: $29.20
End price/share: $130.70
Dividends collected/share: $0.00
Total return: 347.60%
GH Average Annual Return: 21.53%
Starting investment: $10,000.00
Ending investment: $44,749.37
Years: 7.68


GH average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Guardant Health Inc
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. The GH average annual return since 2018 is shown above.

The Average Annual Return on the GH average annual return since 2018 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether GH average annual return since 2018 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the GH average annual return calculation with any dividends reinvested as applicable (on ex-dates).
GH Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree GH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Guardant Health (GH) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

GILD Average Annual Return
GKOS Average Annual Return
GLSI Average Annual Return
GLUE Average Annual Return
GLXY Average Annual Return
GMED Average Annual Return
GNLX Average Annual Return
GNMX Average Annual Return
GNPX Average Annual Return
GOSS Average Annual Return
More Healthcare companies »
 

GH Average Annual Return Since 2018 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.